Nine genes that were closely related to the prognosis of ovarian cancer patients were screened, as follows: IFNG (Interferon Gamma), BIRC5 (Baculoviral IAP Repeat Containing 5), MMP1 (Matrix Metallopeptidase 1), ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2), RB1 (RB Transcriptional Corepressor 1), MYC (MYC Proto-Oncogene, BHLH Transcription Factor), BCL2L1, CD40LG (CD40 Ligand), and PTPN1 (Protein Tyrosine Phosphatase NonReceptor Type 1) (Figure 4(a)). This evidence concerns the gene ERBB2 and ovarian cancer.